RE:RE:mdjbrown...agree, be it today or 30 years ago on a posting Oh Solid, I'm all about LABS. Probably own more than a bunch of you.
I just don't like people spouting factless and untrue information.
Most of the posts on pharma on this board are factless. As proof, everything that was said about pfizer or whatever other pharma has been blown up unrealistically.
My estimation about quarterly revs on yahoo have been way closer to what is actually reported than the astronomical numbers you guys post on here Q after Q.
You want some plausible and fact based info: Eurofarma is most probably LABS client in Brazil. If you look at the timing of it all news wise, it all makes sense.Suppliers on brazilian paperwork for eurofarma don't have the pedigree to supply big pharma. Labs likely needed them to sign the deal.
You want more info? look at all the production technicians hired on linkedin since Brazil GMP announcement. Revs probably about to ramp up unless there was huge turn over, but it all happened in second half of Q1 so realistically, Q2 could be break out quarter.
There was a dronabinol delivery to germany in Q1 and a new order for vapes in australia. Look for info on linkedin.
This is fact based. Most of what you guys say is worthless.